サマリー

遺伝子治療とは、遺伝子を利用して病気の治療や予防を行う実験的な技術です。将来的には、医師が薬や手術の代わりに患者の細胞に遺伝子を挿入することで病気を治療できるようになるかもしれません。

市場分析とインサイト遺伝子治療ベースの薬剤の世界市場
遺伝子治療ベースの薬剤の世界市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX％のCAGRで、2027年にXX百万米ドルに達すると予測されます。
本レポートは、業界標準の正確な分析と高いデータ整合性により、世界の遺伝子治療薬市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つ見事な試みを行っています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができます。その中には、収益面での遺伝子治療ベースの医薬品の世界市場全体のサイズに関する予測も含まれています。
全体として、本レポートは、プレイヤーが競合他社に対して優位に立ち、世界の遺伝子治療ベースの医薬品市場で永続的な成功を収めるために利用できる効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、遺伝子治療ベースの医薬品の世界市場を詳細に調査するために、独自の、そして業界で最も優れた調査・分析手法を用いています。

世界の遺伝子治療ベースの薬剤の範囲と市場規模
遺伝子治療ベースの医薬品市場は、企業別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界のGene Therapy-based Drug市場のプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント分析では、2016年から2027年までの期間における、タイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
ウィルス性遺伝子導入システム
非ウイルス性ジーンデリバリーシステム

アプリケーション別
神経系疾患
癌
その他

地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
U.K.
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
バイオジェン
ノバルティス
ギリアド・サイエンシズ
サレプタ・セラピューティクス
アルナイラム社
アムジェン
スパーク・セラピューティクス（Spark Therapeutics
Akcea Therapeutics
ブルーバード・バイオ
サンウェイ・バイオテック
SIBIONO
AnGes
オーチャード・セラピューティクス
ヒト幹細胞研究所

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy-based Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Gene Therapy-based Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gene Therapy-based Drug Market Perspective (2016-2027)
2.2 Gene Therapy-based Drug Growth Trends by Regions
2.2.1 Gene Therapy-based Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gene Therapy-based Drug Historic Market Share by Regions (2016-2021)
2.2.3 Gene Therapy-based Drug Forecasted Market Size by Regions (2022-2027)
2.3 Gene Therapy-based Drug Industry Dynamic
2.3.1 Gene Therapy-based Drug Market Trends
2.3.2 Gene Therapy-based Drug Market Drivers
2.3.3 Gene Therapy-based Drug Market Challenges
2.3.4 Gene Therapy-based Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy-based Drug Players by Revenue
3.1.1 Global Top Gene Therapy-based Drug Players by Revenue (2016-2021)
3.1.2 Global Gene Therapy-based Drug Revenue Market Share by Players (2016-2021)
3.2 Global Gene Therapy-based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy-based Drug Revenue
3.4 Global Gene Therapy-based Drug Market Concentration Ratio
3.4.1 Global Gene Therapy-based Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy-based Drug Revenue in 2020
3.5 Gene Therapy-based Drug Key Players Head office and Area Served
3.6 Key Players Gene Therapy-based Drug Product Solution and Service
3.7 Date of Enter into Gene Therapy-based Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy-based Drug Breakdown Data by Type
4.1 Global Gene Therapy-based Drug Historic Market Size by Type (2016-2021)
4.2 Global Gene Therapy-based Drug Forecasted Market Size by Type (2022-2027)

5 Gene Therapy-based Drug Breakdown Data by Application
5.1 Global Gene Therapy-based Drug Historic Market Size by Application (2016-2021)
5.2 Global Gene Therapy-based Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gene Therapy-based Drug Market Size (2016-2027)
6.2 North America Gene Therapy-based Drug Market Size by Type
6.2.1 North America Gene Therapy-based Drug Market Size by Type (2016-2021)
6.2.2 North America Gene Therapy-based Drug Market Size by Type (2022-2027)
6.2.3 North America Gene Therapy-based Drug Market Size by Type (2016-2027)
6.3 North America Gene Therapy-based Drug Market Size by Application
6.3.1 North America Gene Therapy-based Drug Market Size by Application (2016-2021)
6.3.2 North America Gene Therapy-based Drug Market Size by Application (2022-2027)
6.3.3 North America Gene Therapy-based Drug Market Size by Application (2016-2027)
6.4 North America Gene Therapy-based Drug Market Size by Country
6.4.1 North America Gene Therapy-based Drug Market Size by Country (2016-2021)
6.4.2 North America Gene Therapy-based Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Gene Therapy-based Drug Market Size (2016-2027)
7.2 Europe Gene Therapy-based Drug Market Size by Type
7.2.1 Europe Gene Therapy-based Drug Market Size by Type (2016-2021)
7.2.2 Europe Gene Therapy-based Drug Market Size by Type (2022-2027)
7.2.3 Europe Gene Therapy-based Drug Market Size by Type (2016-2027)
7.3 Europe Gene Therapy-based Drug Market Size by Application
7.3.1 Europe Gene Therapy-based Drug Market Size by Application (2016-2021)
7.3.2 Europe Gene Therapy-based Drug Market Size by Application (2022-2027)
7.3.3 Europe Gene Therapy-based Drug Market Size by Application (2016-2027)
7.4 Europe Gene Therapy-based Drug Market Size by Country
7.4.1 Europe Gene Therapy-based Drug Market Size by Country (2016-2021)
7.4.2 Europe Gene Therapy-based Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy-based Drug Market Size (2016-2027)
8.2 Asia-Pacific Gene Therapy-based Drug Market Size by Type
8.2.1 Asia-Pacific Gene Therapy-based Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gene Therapy-based Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gene Therapy-based Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Gene Therapy-based Drug Market Size by Application
8.3.1 Asia-Pacific Gene Therapy-based Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gene Therapy-based Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gene Therapy-based Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Gene Therapy-based Drug Market Size by Region
8.4.1 Asia-Pacific Gene Therapy-based Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gene Therapy-based Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gene Therapy-based Drug Market Size (2016-2027)
9.2 Latin America Gene Therapy-based Drug Market Size by Type
9.2.1 Latin America Gene Therapy-based Drug Market Size by Type (2016-2021)
9.2.2 Latin America Gene Therapy-based Drug Market Size by Type (2022-2027)
9.2.3 Latin America Gene Therapy-based Drug Market Size by Type (2016-2027)
9.3 Latin America Gene Therapy-based Drug Market Size by Application
9.3.1 Latin America Gene Therapy-based Drug Market Size by Application (2016-2021)
9.3.2 Latin America Gene Therapy-based Drug Market Size by Application (2022-2027)
9.3.3 Latin America Gene Therapy-based Drug Market Size by Application (2016-2027)
9.4 Latin America Gene Therapy-based Drug Market Size by Country
9.4.1 Latin America Gene Therapy-based Drug Market Size by Country (2016-2021)
9.4.2 Latin America Gene Therapy-based Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy-based Drug Market Size (2016-2027)
10.2 Middle East & Africa Gene Therapy-based Drug Market Size by Type
10.2.1 Middle East & Africa Gene Therapy-based Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gene Therapy-based Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gene Therapy-based Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Gene Therapy-based Drug Market Size by Application
10.3.1 Middle East & Africa Gene Therapy-based Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gene Therapy-based Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gene Therapy-based Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Gene Therapy-based Drug Market Size by Country
10.4.1 Middle East & Africa Gene Therapy-based Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gene Therapy-based Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Therapy-based Drug Introduction
11.1.4 Biogen Revenue in Gene Therapy-based Drug Business (2016-2021)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Therapy-based Drug Introduction
11.2.4 Novartis Revenue in Gene Therapy-based Drug Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Therapy-based Drug Introduction
11.3.4 Gilead Sciences Revenue in Gene Therapy-based Drug Business (2016-2021)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Therapy-based Drug Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy-based Drug Business (2016-2021)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene Therapy-based Drug Introduction
11.6.4 Amgen Revenue in Gene Therapy-based Drug Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene Therapy-based Drug Introduction
11.7.4 Spark Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene Therapy-based Drug Introduction
11.8.4 Akcea Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021)
11.8.5 Akcea Therapeutics Recent Development
11.9 bluebird bio
11.9.1 bluebird bio Company Details
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Gene Therapy-based Drug Introduction
11.9.4 bluebird bio Revenue in Gene Therapy-based Drug Business (2016-2021)
11.9.5 bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Details
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Gene Therapy-based Drug Introduction
11.10.4 Sunway Biotech Revenue in Gene Therapy-based Drug Business (2016-2021)
11.10.5 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Details
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Gene Therapy-based Drug Introduction
11.11.4 SIBIONO Revenue in Gene Therapy-based Drug Business (2016-2021)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Details
11.12.2 AnGes Business Overview
11.12.3 AnGes Gene Therapy-based Drug Introduction
11.12.4 AnGes Revenue in Gene Therapy-based Drug Business (2016-2021)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Details
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Gene Therapy-based Drug Introduction
11.13.4 Orchard Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Details
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Gene Therapy-based Drug Introduction
11.14.4 Human Stem Cells Institute Revenue in Gene Therapy-based Drug Business (2016-2021)
11.14.5 Human Stem Cells Institute Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details